Cite

HARVARD Citation

    Abad, A. et al. (2018). Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. Annals of oncology. pp. 439-444. [Online]. 
  
Back to record